product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
FGF Receptor 3 (C51F2) Rabbit mAb
catalog :
4574
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
C51F2
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation
citations: 5
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; human; fig 6a
  • western blot; human; fig 4a
Inaguma S, Ito H, Riku M, Ikeda H, Kasai K. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Oncotarget. 2015;6:28257-68 pubmed publisher
  • western blot; human
Tohyama O, Matsui J, Kodama K, Hata Sugi N, Kimura T, Okamoto K, et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747 pubmed publisher
  • western blot; human
Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77 pubmed publisher
Hayes M, McCarthy K, Jin A, Oliveira M, Iyer S, Garcia S, et al. Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma. Cell Stem Cell. 2018;22:414-427.e6 pubmed publisher
Wang R, Wang L, Li Y, Hu H, Shen L, Shen X, et al. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res. 2014;20:4107-14 pubmed publisher
product information
SKU :
4574S
Product-Name :
FGF Receptor 3 (C51F2) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
RTK
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
165, 145 and 125
Host :
Rabbit
Target :
FGFR3
Primary-Protein :
FGFR3
Alt-Names :
ACH,CD333,CEK2,FGFR-3,FGFR3,Fibroblast growth factor receptor 3,HSFGFR3EX,JTK4,achondroplasia, thanatophoric dwarfism,hydroxyaryl-protein kinase,tyrosine kinase JTK4
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.